2016
DOI: 10.1001/jamaophthalmol.2016.0794
|View full text |Cite
|
Sign up to set email alerts
|

Age-Related Macular Degeneration and Quality of Life in Latinos

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
24
0
1

Year Published

2016
2016
2019
2019

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 25 publications
(26 citation statements)
references
References 46 publications
(70 reference statements)
1
24
0
1
Order By: Relevance
“…40 A recent population-based study conducted in adult Latino population revealed overall NEI-VFQ-25 scores of 59.5 (95% CI, 50.8-68.1) for those with latestage AMD and 79.4 (95% CI, 72.5-86.1) for those with early-stage AMD. 21 The current study showed that patients with similar visual acuity experience similar overall impairment in QoL whether they had early-stage glaucoma or AMD, despite the fact that they essentially affect visual function through different mechanisms. They both experience loss of QoL mainly in subgroups of general health and general vision.…”
mentioning
confidence: 52%
See 4 more Smart Citations
“…40 A recent population-based study conducted in adult Latino population revealed overall NEI-VFQ-25 scores of 59.5 (95% CI, 50.8-68.1) for those with latestage AMD and 79.4 (95% CI, 72.5-86.1) for those with early-stage AMD. 21 The current study showed that patients with similar visual acuity experience similar overall impairment in QoL whether they had early-stage glaucoma or AMD, despite the fact that they essentially affect visual function through different mechanisms. They both experience loss of QoL mainly in subgroups of general health and general vision.…”
mentioning
confidence: 52%
“…7,14-21,31-36 They revealed that total scores of general sighted population was significantly higher compared with AMD or POAG patients. 13,14,17,21 Mangione et al 13 observed that overall scores were lower for the patients with various chronic eye diseases including AMD (67.1 ± 13.4) and POAG (80.2 ± 12.5) compared with a reference sample of participants with no evidence of underlying eye disease (88.1 ± 15.3). This suggests that NEI-VFQ-25 is sensitive to different levels of visual function in the better eye of patients with AMD and POAG.…”
Section: Discussionmentioning
confidence: 98%
See 3 more Smart Citations